Citation: | LV L, ZHAI J, LI Y C, et al. Quantitative CT Analysis of Body Composition in Maintenance Hemodialysis Patients[J]. CT Theory and Applications, 2023, 32(2): 256-262. DOI: 10.15953/j.ctta.2022.050. (in Chinese). |
[1] |
ZAYOUR D, DAOUK M, MEDAWAR W, et al. Predictors of bone mineral, density in patients on hemodialysis[J]. TranspIanlation Proceedings, 2004, 36(5): 1297−1301. doi: 10.1016/j.transproceed.2004.05.069
|
[2] |
WU C C, LIOU H H, SU P F, et al. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients[J]. Nephrol Dial Transplant, 2011, 26: 3689−3695. doi: 10.1093/ndt/gfr057
|
[3] |
程晓光, 王亮, 曾强, 等. 中国定量CT (QCT)骨质疏松症诊断指南(2018)[J]. 中国骨质疏松杂志, 2019,25(6): 733−737.
CHENG X G, WANG L, ZENG Q, et al. The China guideline for the diagnosis criteria of oste oporosis with quantitative computed tomography (QCT) (2018)[J]. Chinese Journal of Osteoporosis, 2019, 25(6): 733−737. (in Chinese).
|
[4] |
夏维波, 章振林, 林华, 等. 原发性骨质疏松症诊疗指南(2017)[J]. 中国骨质疏松杂志, 2019,25(3): 281−309. doi: 10.3969/j.issn.1006-7108.2019.03.001
XIA W B, ZHANG Z L, LIN H, et al. Guidelines for the diagnosis and management of primary osteoporosis (2017)[J]. Chinese Journal of Osteoporosis, 2019, 25(3): 281−309. (in Chinese). doi: 10.3969/j.issn.1006-7108.2019.03.001
|
[5] |
胡耀, 黄朝莉, 徐秀蓉. 维持性血液透析患者骨密度测定与相关指标分析[J]. 现代临床医学, 2012,38(1): 13−14. doi: 10.3969/j.issn.1673-1557.2012.01.005
HU Y, HUANG Z L, XU X R. To analysis bone mineral density and related indicators in patients of maintaining hemodialysis[J]. Journal of Modern Clinical Medicine, 2012, 38(1): 13−14. (in Chinese). doi: 10.3969/j.issn.1673-1557.2012.01.005
|
[6] |
MOSCOVICI A, SPRAGUE S M. Osteoprosis and chronic kidney disease[J]. Seminars in Dialysis, 2007, 20(5): 423−430. doi: 10.1111/j.1525-139X.2007.00319.x
|
[7] |
刘铁滨, 王维. 长期血液透析患者腰椎骨密度定量CT的检测及意义[J]. 实用放射学杂志, 2004,20(12): 1104−106. doi: 10.3969/j.issn.1002-1671.2004.12.014
LIU T B, WANG W. Measurement of lumbar bone mineral density with quantitative computed tomography in hemodialysis patients[J]. Journal of Practical Radiology, 2004, 20(12): 1104−106. (in Chinese). doi: 10.3969/j.issn.1002-1671.2004.12.014
|
[8] |
MIRFAKHRAEE S, SAKHAEE K, ZERWEKH J, et al. Risk factors for diminished bone mineral density among male hemodialysis patients: A cross-sectional study[J]. Arch Osteoporos, 2012, 7(1/2): 283−290. doi: 10.1007/s11657-012-0110-3
|
[9] |
SHEU Y, MARSHALL L M, HOLTON K F, et al. Abdominal body composition measured by quantitative computed tomography and risk of non-spine fractures: The osteoporotic fractures in men (MrOS) study[J]. Osteoporosis International, 2013, 24(8): 2231−2241. doi: 10.1007/s00198-013-2322-9
|
[10] |
CHENG X, ZHANG Y, WANG C, et al. The optimal anatomic sitefor a single slice to estimate the total volume of visceraladipose tissue by using the quantitative computed tomography (QCT) in Chinese population[J]. European Journal of Clinical Nutrition, 2018, 72(11): 1567−1575. doi: 10.1038/s41430-018-0122-1
|
[11] |
丁奕, 田娜, 周晓玲, 等. 肥胖与IgA肾病患者独立肾脏风险因子的相关性分析[J]. 中华肾脏病杂志, 2017,33(5): 321−326. doi: 10.3760/cma.j.issn.1001-7097.2017.05.001
DING Y, TIAN N, ZHOU X L, et al. Correlation analysis of obesity with independent renal risk factors in patients with IgA nephropathy[J]. Chinese Journal of Nephrology, 2017, 33(5): 321−326. (in Chinese). doi: 10.3760/cma.j.issn.1001-7097.2017.05.001
|
[12] |
刘建强, 贾冶, 许钟镐, 等. 肥胖与慢性肾脏疾病: 脂肪组织与肾脏炎症及纤维化的关系[J]. 中华肾脏病杂志, 2017, 33(12): 956-960.
LIU J Q, JIA Y, XU Z H, et al. Obesity and chronic kidney disease: The relationship between adipose tissue and kidney inflammation and fibrosis[J]. Chinese Journal of Nephrology, 2017, 33(12): 956-960. (in Chinese).
|
[13] |
罗文荣, 姚书东, 孙梅琴. 血液透析对肾病肥胖女性患者内分泌相关指标的影响[J]. 中国妇幼保健, 2021,36(14): 3195−3198. DOI: 10.19829/j.zgfybj.issn.1001-4411.2021.14.009.
LUO W R, YAO S D, SUN M Q. Effect of hemodialysis on endocrine-related indicators in obese women with kidney disease[J]. Maternal and Child Health Care of China, 2021, 36(14): 3195−3198. DOI: 10.19829/j.zgfybj.issn.1001-4411.2021.14.009. (in Chinese).
|
[14] |
晏乘曦, 唐光才, 程晓光. 肌少症的定量测量现状及研究进展[J]. 中国骨质疏松杂志, 2018,24(6): 814−819. doi: 10.3969/j.issn.1006-7108.2018.06.021
YAN C X, TANG G C, CHENG X G. State of the art of quantitative me asurement of sarcopenia[J]. Chinese Journal of Osteoporosis, 2018, 24(6): 814−819. (in Chinese). doi: 10.3969/j.issn.1006-7108.2018.06.021
|
[15] |
耿楠, 孔明, 陈煜, 等. 第三腰椎骨骼肌指数在终末期肝病营养诊断中的应用价值[J]. 临床肝胆病杂志, 2021,37(10): 2493−2496. doi: 10.3969/j.issn.1001-5256.2021.10.050
GENG N, KONG M, CHENG Y, et al. Value of L3 skeletal muscle index in nutritional diagnosis of end-stage liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2493−2496. (in Chinese). doi: 10.3969/j.issn.1001-5256.2021.10.050
|
[16] |
FAHAL I H. Uraemic sareopenia: Aetiology and implications[J]. Nephml Dial Transplant, 2014, 29(9): 1655−1665. doi: 10.1093/ndt/gft070
|
[17] |
PRADO C M, LIEFFERS J R, MCCARGAR L J, et al. Prevalence andclinical implications of sarcopenic obesity in patients with solidtumours of the respiratory and gastrointestinal tracts: Apopulation-based study[J]. Lancet Oncology, 2008, 9(7): 629. doi: 10.1016/S1470-2045(08)70153-0
|